The new AAII Contrarian Sentiment Indicator ranks our current investor sentiment against historical levels to identify directional bias and measure the proportion of opinions.

Panelists discuss how treatment selection between combination immunotherapy (IO) and chemotherapy alone should favor the FDA-approved carboplatin-paclitaxel-retifanlimab regimen for most patients with ...

Learn everything you need to know about key performance indicators.